Riskpilot← Back to searchSign inGet full accessDaliab AB
ABActiveOrg 5591438949Carlgrensvägen 4General medical practice activities · NACE 8621Est. 20181 employees
Revenue 2024
SEK 1,5M
-18% vs 2023
EBITDA margin
32.4%
-45% vs 2023
Equity ratio
48.2%
Financial strength
Net profit 2024
SEK 293K
-43% vs 2023
| Revenue | SEK 1,5M | -18% |
| EBITDA | SEK 482K | -45% |
| Net profit | SEK 293K | -43% |
| Total assets | SEK 2,1M | +10% |
| Equity | SEK 991K | +10% |
| Employees | 1 | — |
Legal name
Daliab AB
Org number
5591438949
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
4 januari 2018
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva läkarkonsultationer, hälso- och sjukvård. Bolaget ska också bedriva konsultverksamhet inom elektronik, mätteknik och testsystemutveckling.
Address
Carlgrensvägen 4
Email
lina_555@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 333 | 594 | 976 | 1 103 | 1 201 | 1 818 | 1 487 |
| Staff expenses | — | — | — | — | — | — | — |
| EBITDA | 286 | 426 | 438 | 540 | 634 | 869 | 482 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | 286 | 426 | 438 | 540 | 634 | 869 | 482 |
| Net financials | — | — | −1 | −1 | −2 | 6 | 23 |
| Profit before tax | 286 | 319 | 327 | 404 | 473 | 654 | 374 |
| Tax | −63 | −68 | −70 | −84 | −98 | −137 | −81 |
| Net profit | 223 | 251 | 257 | 320 | 375 | 517 | 293 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | 341 | 663 | 804 | 1 088 | 1 480 | 1 865 | 2 056 |
| Equity | 273 | 304 | 342 | 537 | 581 | 898 | 991 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 68 | 252 | 247 | 200 | 388 | 235 | 201 |
| Total debt | 68 | 252 | 247 | 200 | 388 | 235 | 201 |
EBITDA margin
32.4%
This company
15.8%
Market median
+105% vs market
20182024
Equity ratio
48.2%
This company
38.2%
Market median
+26% vs market
20182024
Return on equity
29.6%
This company
18.4%
Market median
+61% vs market
20182024
Net profit margin
19.7%
This company
8.1%
Market median
+143% vs market
20182024
Asset turnover
0.72×
This company
1.12×
Market median
-36% vs market
20182024
Debt / equity
1.07×
This company
0.62×
Market median
-73% vs market
20182024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
LP Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 | — | — |
EL Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Daliab AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Peder Daniel Åberg | Deputy Chief Executive Officer | 0 companies |
| Eva Lina Marie Åberg | Chief Executive Officer | 0 companies |